Search clinical trials for: Non-steroidal mineral corticoid receptor antagonists (nsMRA)

Total 3068 results

Bayer

Active, not recruiting

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice (FINEGUST)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Japan, Spain, Netherlands, United Kingdom, Denmark, United States
Bayer

Completed

A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How They Are Used, What Side Effects They Have, and How Satisfied People Who Receive Them Are in the US

Heart Failure | Type 2 Diabetes Mellitus | Chronic Kidney Disease

United States
Idorsia Pharmaceuticals Ltd.
Carelon Research

Active, not recruiting

Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant)

Insomnia Disorder

United States
The First Affiliated Hospital with Nanjing Medical...
National Natural Science Foundation of China

Unknown

Different Platelet Activities Between Intracoronary and Peripheral Blood in Coronary Artery Disease Patients (DPABIAP)

Coronary Artery Disease

China
Beijing Anzhen Hospital

Unknown

Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis

Percutaneous Coronary Intervention

China
Asan Medical Center

Recruiting

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent (OPTIMIZE-APT)

Coronary Artery Disease

Korea, Republic of
Centre de Recherche de l'Institut Universitaire...

Completed

Aspirin Versus Aspirin+Clopidogrel as Antithrombotic Treatment Following TAVI (ARTE)

Myocardial Infarction | Stroke | Bleeding | Aortic Valve Disease

Canada, Chile, Spain
Shire

Completed

A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese Participants

Hereditary Angioedema (HAE)

Japan
Massachusetts General Hospital
Shire Human Genetic Therapies, Inc.

Completed

Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE (IHA)

Hereditary Angioedema

United States
Cairo University

Not yet recruiting

Pirfenidone Use in Asbestosis Patients: Efficacy and Prognosis

Asbestosis
Shire
Takeda

Completed

FIRAZYR General Drug Use-Results Survey (Japan)

Hereditary Angioedema (HAE)

Japan
Shire
PPD

Completed

Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced Angioedema

Angiotensin Converting Enzyme Inhibitor Induced Angioedema

United States, Canada, United Kingdom, Israel
Shire

Completed

A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

Hereditary Angioedema

United States, Australia, Israel, Canada, Hungary, Romania, Russian Federation, South Africa, Ukraine
Shire

Completed

A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema

Hereditary Angioedema (HAE)

United States, Canada, Australia, Austria, Colombia, Germany, Hungary, Israel, Italy, Spain
Sanofi

Completed

Efficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee Osteoarthritis

Joint Disease

United States, Austria, Czech Republic, Germany, Poland
IlDong Pharmaceutical Co Ltd
Asan Medical Center

Terminated

Safety Study of APD-791 With Aspirin and/or Clopidogrel (TG1C)

Acute Coronary Syndrome
Takeda

Recruiting

A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema

Hereditary Angioedema (HAE)

Japan
Shire

Completed

Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers

Hereditary Angioedema (HAE)

United States
Vanderbilt University Medical Center

Completed

Mitochondria and Chronic Kidney Disease (MitoCKD)

Mitochondrial Diseases | Hemodialysis-Induced Symptom

United States
Vanderbilt University Medical Center
Shire

Terminated

Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema

ACE Inhibitor-associated Angioedema

United States
Takeda

Completed

A Study of Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary Angioedema

Hereditary Angioedema

Japan
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema

Angioneurotic Edema

United States
University of Alabama at Birmingham
Mayo Clinic

Recruiting

Safety and Tolerability of Pirfenidone in Acute Pancreatitis

Pancreatitis, Acute

United States
Vanderbilt University Medical Center
Renal Research Institute; Pharvaris Netherlands B.V.

Recruiting

Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor

Intradialytic Hypotension

United States
Shire
Jerini AG

Completed

EASSI - Evaluation of the Safety of Self-Administration With Icatibant (EASSI)

Hereditary Angioedema

Spain, Argentina, Austria, Denmark, France, Germany, Israel, Italy, Switzerland, United Kingdom
Tillotts Pharma AG
Zeria Pharmaceutical

Completed

Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis

Active Ulcerative Colitis

China
Baylor Research Institute
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation

Heart Diseases | Cardiovascular Diseases | Coronary Disease

United States
Radboud University Medical Center

Recruiting

The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction and the Effect on Intramyocardial Haemorrhage (STOP-IMH)

ST Elevation Myocardial Infarction

Netherlands
Beth Israel Deaconess Medical Center
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Recruiting

The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry

Healthy | Platelet Activation Testing Before/After Anti-platelet Therapy

United States
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin (WILLOW TREE)

Acute Coronary Syndrome

United Kingdom
Boca Raton Regional Hospital
AstraZeneca; Ottawa Heart Institute Research Corporation

Completed

Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET)

Saphenous Vein Graft Disease

United States, Canada
Duke University

Completed

GM03 - Platelet RNA Signatures of Aspirin

Aspirin | Platelet Aggregation Inhibitors | Ticagrelor | RNA

United States
Assiut University

Unknown

Role of Anti-platelet in Treatment of Acute Ischemic Stroke

Stroke
Chuncheon Sacred Heart Hospital

Unknown

Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk (CESAC-AF)

Atrial Fibrillation
Dexa Medica Group

Completed

Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

Indonesia
Bristol-Myers Squibb

Completed

Ex Vivo Human Thrombosis Chamber Study

Cardiovascular Disease

United States
University of Maryland, Baltimore

Completed

CES1 Carriers in the PAPI Study

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease | Aspirin Sensitivity | Clopidogrel, Poor Metabolism of | Platelet Dysfunction | Artery Occlusion | Platelet Thrombus

United States
Johns Hopkins University

Completed

Pharmacogenomics of Antiplatelet Response - I (PARes-I)

Coronary Artery Disease | Platelet Aggregation | Platelet Transcriptome

United States
Joo-Yong Hahn

Recruiting

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3 (SMART-CHOICE3)

Coronary Artery Disease

Korea, Republic of
Shanghai Tong Ren Hospital

Recruiting

A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients (TIGER-diabetes)

Acute Coronary Syndrome Patients With Diabetes After PCI

China
Yuhan Corporation

Completed

Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients

Ischemic Stroke

Korea, Republic of
University of Maryland, Baltimore
National Heart, Lung, and Blood Institute (NHLBI); National Institute of General...

Completed

Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)

Coronary Heart Disease | Platelet Aggregation Inhibitors

United States
Ruijin Hospital

Completed

Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft Surgery (DACAB)

Coronary Artery Bypass | Antiplatelet Agents

China
NYU Langone Health

Completed

Antiplatelet Therapy in HIV

Cardiovascular Diseases | Inflammation | HIV

United States
Hamilton Health Sciences Corporation
Bristol-Myers Squibb

Completed

Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study (PAPA CABG)

Coronary Artery Disease | Coronary Artery Bypass Grafting

Canada
Arteriogenesis Competence Network

Completed

The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)

Peripheral Arterial Disease

Switzerland, Germany
Kawut, Steven, MD
National Heart, Lung, and Blood Institute (NHLBI); Columbia University

Completed

A Study of Aspirin and Clopidogrel in Patients With Idiopathic Pulmonary Arterial Hypertension

Hypertension, Pulmonary

United States
IlDong Pharmaceutical Co Ltd
Asan Medical Center

Terminated

Dose-escalation, Repeated and Single Oral Dosing Study

Acute Coronary Syndrome
Shire

Completed

Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema

Angioedema

United States
Dr. Falk Pharma GmbH

Completed

Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)

Crohn's Disease

Germany

Search clinical trials for: Non-steroidal mineral corticoid receptor antagonists (nsMRA)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations